Editorial Staff

  • Managing Editor:

    Kerri Fitzgerald
  • Circulation Manager:

    Bonnie Shannon
  • National Account Manager:

    Michael Sussman
  • Senior Graphic Production Manager:

    Andrea Steiger
  • Editorial Correspondence

  • Kerri Fitzgerald, Managing Editor
  • HMP Communications, Life Science Offices

    104 Windsor Center Drive, Suite 200

    East Windsor, NJ 08520
  • Telephone: 610-560-0500, ext. 370

    Fax: 610-560-4146
  • Email: kfitzgerald@hmpcommunications.com
  • February 2010 | Volume 2
    Charles Boersig

    With Legislation Stalled, Reformers Regroup

    Confronted with public opposition, a unified minority party, and an election loss that changed the balance of power in the US Senate, healthcare reform efforts have entered a new phase featuring talk of bipartisan cooperation and a healthcare summit at the White House. Democrats continue to hold majorities in the House of Representatives and the Senate, but after months of debate and several narrowly won votes, their voluminous healthcare bills may no longer be viable. The opposition is calling for reformers to toss out the current Hous

    continue reading
    February 2010   |   1,490 reads
    Charles Boersig

    CMS Report Depicts Government’s Increasing Role

    Spending on healthcare in the United States totaled $2.5 trillion in 2009, a 5.7% increase, and accounted for 17.3% of the nation’s gross domestic product (GDP). Although job losses contributed to a reduction in private insurance enrollment, insurers saw better growth in private health insurance premiums than during 2008. Growth in public-sector healthcare spending outpaced increases in private outlays, and the government’s share of the national healthcare bill is projected to exceed 50% by 2012, according to projections rele

    continue reading
    February 2010   |   2,034 reads
    Kevin L. Carter

    In the discussion of healthcare reform in the United States, primary care physicians have been focused on as the point practitioners in the drive to deliver higher-quality care and to lower costs. Meanwhile, patient populations have increased, growing older and more complex, while net income for primary care physicians dropped by 10.2% between 1995 and 2003. Studies have indicated that greater patient satisfaction is associated with perceived and actual visit duration, and that a poor provider relationship may lead to lesser medication adherence.

    The investigators wished to deter

    continue reading
    February 2010   |   1,989 reads

    Philadelphia—Golimumab inhibited progression of radiographic damage to joints in patients with psoriatic arthritis (PSA), according to 52-week results of the randomized, controlled the GO-REVEAL (Golimumab-Randomized Evaluation of Safety and Efficacy in Subjects with Psoriatic Arthritis Using a Human Anti-TNF Monoclonal Antibody) study reported at the ACR meeting. Arthur F. Kavanaugh, MD, of the University of California San Diego presented results a late-breaking news session.

    Golimumab, an injectable anti-tumor necrosis factor (TNF

    continue reading
    February 2010   |   1,399 reads

     

    Product SpotlightVictoza(liraglutide)

    continue reading
    February 2010   |   3,234 reads